Though a helpful tool for some, achieving long-term, sustainable weight loss through GLP-1s is challenging
Exclusivamente para investigacin cientfica de laboratorio
### How Each Drug Performs at Key Milestones | Milestone | Orforglipron (36 mg) | Oral Semaglutide (50 mg) | Tirzepatide (15 mg) | |-----------|---------------------|-------------------------|---------------------| | **4 weeks** | ~2-3% | ~2-3% | ~3-4% | | **12 weeks** | ~6-8% | ~6-7% | ~8-10% | | **24 weeks** | ~10-12% | ~10-11% | ~14-16% | | **36 weeks** | ~14-15% | ~12-13% | ~17-19% | | **68-72 weeks** | ~15%+ (projected) | ~15.1% | ~20-22.5% | For detailed semaglutide weight loss trajectories, see our [semaglutide weight loss results timeline](/guides/semaglutide-weight-loss-results-timeline-what-to-expect)
95% CI, 95% confidence interval
Kronik yorgunluk ve enerji dkl Baklk sisteminin zayflamas, sk hastalanma Ciltte matlama, yalanma belirtilerinin hzlanmas Kas ve eklem arlar Odaklanma gl ve zihinsel yorgunluk Sindirim problemleri ve karacier fonksiyon bozukluklar Enfeksiyonlara kar diren kayb Glutatyon eksikliini nlemek iin beslenme dzenine dikkat etmek, glutatyon seviyesini destekleyen besinler tketmek ve dzenli doktor kontrolleri yaptrmak nemlidir
doi: 10.1016/j.jid.2020.02.040 64 ElliottCGHamiltonDW
